Navigate to
-
Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...
-
90-day supply Depending on plan design, you may be able to get a 90-day supply of your medicine for less than three 30-day fills. Registered pharmacists Dedicated pharmacists can help get your meds...
-
Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Recent studies have reported an incidence of TA-TMA spanning from 2% to 39%. Such wide variability is thought to stem from inconsistent diagnostic definitions as well as the inclusion of both...
-
Appetite For Change uses food as a tool to build health, wealth and social change. “For youth experiencing homelessness, the Prime Together Foundation’s donation helps The Bridge for Youth go...
-
References Ma L, Guo H, Zhao Y, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Nature. 2024;9(336). McDowell S. Liquid biopsies: past, present, and future....
-
Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...
-
Abby Kim, PharmD, BCOP, shares how artificial intelligence and novel screening tools are helping to prevent and detect cancer better and sooner
PA Sub-Categories: Specialty drugs Prime Article: Stories